BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6965486)

  • 1. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix.
    Ishiguro T; Sugitachi I; Katoh K
    Gynecol Oncol; 1980 Feb; 9(1):80-5. PubMed ID: 6965486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythrocyte changes in cervix neoplasms and its preliminary stages].
    Linke A; Kruschwitz S; Gemende I; Männchen E; Fehse KH; Voss J
    Z Arztl Fortbild (Jena); 1977 Mar; 71(5):236-9. PubMed ID: 868103
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune competence and survival in patients with advanced cervical cancer: peripheral lymphocyte counts.
    DiSaia PJ; Morrow CP; Hill A; Mittelstaedt L
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):449-51. PubMed ID: 689945
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteinase-inhibitor activity in sera of patients with carcinoma of the cervix uteri.
    Benítez-Bribiesca L; Freyre-Horta R; Villalobos-Ramírez M; Pastrana L
    Arch Invest Med (Mex); 1987; 18(3):187-92. PubMed ID: 3501277
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunocompetent cells in uterine cervical lesions of human papillomavirus origin.
    Syrjänen KJ
    Gynecol Obstet Invest; 1983; 16(6):327-40. PubMed ID: 6317528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Rand RJ; Jenkins DM; Bulmer R
    Clin Exp Immunol; 1978 Jul; 33(1):159-65. PubMed ID: 309370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma reduced and total ascorbic acid in human uterine cervix dysplasias and cancer.
    Romney SL; Basu J; Vermund S; Palan PR; Duttagupta C
    Ann N Y Acad Sci; 1987; 498():132-43. PubMed ID: 3475995
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular immunity in squamous cell carcinoma of the uterine cervix.
    Levy S; Kopersztych S; Musatti CC; Souen JS; Salvatore CA; Mendes NF
    Am J Obstet Gynecol; 1978 Jan; 130(2):160-4. PubMed ID: 304309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper and zinc levels in serum from patients with abnormalities of the uterine cervix.
    Grail A; Norval M
    Acta Obstet Gynecol Scand; 1986; 65(5):443-7. PubMed ID: 3776486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins in carcinoma of the uterine cervix.
    Plesnicar S
    Acta Radiol Ther Phys Biol; 1972 Feb; 11(1):37-47. PubMed ID: 4623041
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immunity in cervical intraepithelial neoplasia.
    Park TK; Kim SN; Choi DH; Lee CH
    Asia Oceania J Obstet Gynaecol; 1992 Jun; 18(2):171-5. PubMed ID: 1503541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current approach to the treatment of early forms of cervix cancer].
    Vinnitskaia VK; Kokhanevich EV; Dziubko NIa; Grinevich IuA; Dovbishchenko VA
    Vopr Onkol; 1985; 31(11):38-44. PubMed ID: 3878037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological status in cervical cancer in relation to pelvic irradiation.
    Chandra M; Chander S
    Indian J Med Res; 1986 Oct; 84():413-7. PubMed ID: 3781598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Frequency of HPV infection and the level of ascorbic acid in serum of women with cervix dysplasia].
    Kwaśniewska A; Tukendorf A; Semczuk M
    Med Dosw Mikrobiol; 1996; 48(3-4):183-8. PubMed ID: 9182140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cell numbers and activities of lymphocyte-subpopulations in the progress of uterine cervical cancer.
    Ueda K; Nakamori H; Umesaki N; Sako H; Hayashi M
    Osaka City Med J; 1975; 21(2):97-109. PubMed ID: 1230725
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular immunity in carcinoma of the uterine cervix.
    Lambert B; Boushira M; Pelletier M; Montplaisir S
    Gynecol Oncol; 1984 Mar; 17(3):394-5. PubMed ID: 6608476
    [No Abstract]   [Full Text] [Related]  

  • 20. [T and B lymphocytes in patients with preinvasive or microinvasive carcinoma of the uterine cervix (author's transl)].
    Ishiguro T; Sugitachi I; Katoh K
    Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):277-81. PubMed ID: 314482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.